| 2026 | Intermittent Fasting and Risk of Diabetic Retinopathy: Retrospective Data from the National Health and Nutrition Examination Survey
| NUTRIENTS |
| 2026 | Effectiveness and Safety of Finerenone in Patients With Diabetic Kidney Disease: A Real-World Observational Study | DIABETES OBESITY & METABOLISM |
| 2026 | Impaired insulin secretion via the Wnt5a/β-catenin pathway contributes to diabetes development in pancreatic cancer
| EXPERIMENTAL AND MOLECULAR MEDICINE |
| 2025 | Protective Role of Serum β-Hydroxybutyrate in Early Diabetic Kidney Disease: A Longitudinal Study
| DIABETES THERAPY |
| 2025 | Metabolic Surgery for Obese Type 2 Diabetes: Korean Multicenter Cohort Study
| OBESITY SURGERY |
| 2025 | Nutriomics and artificial intelligence nutrition obesity cohort (NAINOC): a design paper for a prospective cohort for nutrition and obesity research
| CLINICAL HYPERTENSION |
| 2025 | The Impact of Ketogenic Capacity on Lipid Profile in Individuals with Prediabetes or Newly Diagnosed Type 2 Diabetes
| INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES |
| 2025 | Sodium-Glucose Cotransporter-2 Inhibitor Enhances Hepatic Gluconeogenesis and Reduces Lipid Accumulation via AMPK-SIRT1 Activation and Autophagy Induction
| Endocrinology and Metabolism(대한내분비학회지) |
| 2025 | Synergistic benefit of thiazolidinedione and sodium-glucose cotransporter 2 inhibitor for metabolic dysfunction-associated steatotic liver disease in type 2 diabetes: a 24-week, open-label, randomized controlled trial
| BMC MEDICINE |
| 2025 | Effectiveness and Safety of Oral Quadruple Combination Therapy in Patients with Type 2 Diabetes: A Systematic Review and Meta-Analysis
| Endocrinology and Metabolism(대한내분비학회지) |
| 2025 | Potential Impact of Choline Alphoscerate on Depressive Symptoms in Association with Insulin Resistance in Elderly Patients with Type 2 Diabetes
| JOURNAL OF CLINICAL MEDICINE |
| 2025 | Association between low fasting glucose of the living donor and risk of graft loss in the recipient after liver transplantation
| SCIENTIFIC REPORTS |
| 2024 | Metabolic Dysfunction-Associated Steatotic Liver Disease in Type 2 Diabetes Mellitus: A Review and Position Statement of the Fatty Liver Research Group of the Korean Diabetes Association | DIABETES & METABOLISM JOURNAL |
| 2024 | SGLT2 Inhibitor Use and Risk of Dementia and Parkinson Disease Among Patients With Type 2 Diabetes | NEUROLOGY |
| 2024 | Association of sodium-glucose cotransporter 2 inhibitor use with risk of osteoporotic fracture among older women: A nationwide, population-based cohort study | DIABETES RESEARCH AND CLINICAL PRACTICE |
| 2024 | Intact ketogenesis predicted reduced risk of moderate-severe metabolic-associated fatty liver disease assessed by liver transient elastography in newly diagnosed type 2 diabetes | FRONTIERS IN ENDOCRINOLOGY |
| 2024 | Association of Muscle Mass Loss with Diabetes Development in Liver Transplantation Recipients | DIABETES & METABOLISM JOURNAL |
| 2023 | Clinical Effects of a Home Care Pilot Program for Patients with Type 1 Diabetes Mellitus: A Retrospective Cohort Study | DIABETES & METABOLISM JOURNAL |
| 2023 | Reply to Comment on Intermittent Fasting is Associated with a Decreased Risk of Age-related Macular Degeneration | AMERICAN JOURNAL OF OPHTHALMOLOGY |
| 2023 | Increased expression of sodium-glucose cotransporter 2 and O-GlcNAcylation in hepatocytes drives non-alcoholic steatohepatitis | METABOLISM-CLINICAL AND EXPERIMENTAL |
| 2023 | β-hydroxybutyrate as a biomarker of β-cell function in new-onset type 2 diabetes and its association with treatment response at 6 months | Diabetes and Metabolism |
| 2023 | Highly selective electrochemical quantitation of creatinine based on its chemical reaction with 3,5-dinitrobenzoate | JOURNAL OF ELECTROANALYTICAL CHEMISTRY |
| 2023 | Myosteatosis: a potential missing link between hypertension and metabolic disorder in the Asian population | Hypertension Research |
| 2023 | Impaired ketogenesis is associated with metabolic-associated fatty liver disease in subjects with type 2 diabetes | Frontiers in Endocrinology |
| 2023 | Increased risk of incident diabetes after therapy with immune checkpoint inhibitor compared with conventional chemotherapy: A longitudinal trajectory analysis using a tertiary care hospital database | Metabolism: Clinical and Experimental |
| 2022 | Intermittent Fasting Is Associated With a Decreased Risk of Age-Related Macular Degeneration | American Journal of Ophthalmology |
| 2022 | The effects of the voglibose on non-alcoholic fatty liver disease in mice model | SCIENTIFIC REPORTS |
| 2022 | Protective Effect of Delta-Like 1 Homolog Against Muscular Atrophy in a Mouse Model | Endocrinology and Metabolism(대한내분비학회지) |
| 2022 | Tolerability and Effectiveness of Switching to Dulaglutide in Patients With Type 2 Diabetes Inadequately Controlled With Insulin Therapy | Frontiers in Endocrinology |
| 2022 | A GLP-1/GLP-2 receptor dual agonist to treat NASH: Targeting the gut-liver axis and microbiome | HEPATOLOGY |
| 2022 | Effectiveness and safety of teneligliptin added to patients with type 2 diabetes inadequately controlled by oral triple combination therapy: A multicentre, randomized, double-blind, and placebo-controlled study | Diabetes, Obesity and Metabolism |
| 2022 | Sodium Glucose Cotransporter-2 Inhibitors as an Add-on Therapy to Metformin Plus Dipeptidyl Peptidase-4 Inhibitor in Patients with Type 2 Diabetes | Yonsei Medical Journal |
| 2022 | Ezetimibe combination therapy with statin for non-alcoholic fatty liver disease: an open-label randomized controlled trial (ESSENTIAL study) | BMC Medicine |
| 2022 | Renal Tubular Damage Marker, Urinary N-acetyl-beta-D-Glucosaminidase, as a Predictive Marker of Hepatic Fibrosis in Type 2 Diabetes Mellitus | Diabetes and Metabolism Journal |
| 2021 | Targeting PLD2 in adipocytes augments adaptive thermogenesis by improving mitochondrial quality and quantity in mice | Journal of Experimental Medicine |
| 2021 | Association between pancreatic fibrosis and development of pancreoprivic diabetes after pancreaticoduodenectomy | Scientific Reports |
| 2021 | Uric Acid Variability as a Predictive Marker of Newly Developed Cardiovascular Events in Type 2 Diabetes | Frontiers in Cardiovascular Medicine |
| 2021 | Proteinuria as a significant predictive factor for the progression of carotid artery atherosclerosis in non-albuminuric type 2 diabetes | Diabetes Research and Clinical Practice |
| 2021 | Ipragliflozin, an SGLT2 Inhibitor, Ameliorates High- Fat Diet-Induced Metabolic Changes by Upregulating Energy Expenditure through Activation of the AMPK/SIRT1 Pathway | Diabetes and Metabolism Journal |
| 2021 | Magnetic Resonance Imaging-Visible Perivascular Spaces in the Basal Ganglia Are Associated With the Diabetic Retinopathy Stage and Cognitive Decline in Patients With Type 2 Diabetes | Frontiers in Aging Neuroscience |
| 2021 | Non-Laboratory-Based Simple Screening Model for Nonalcoholic Fatty Liver Disease in Patients with Type 2 Diabetes Developed Using Multi-Center Cohorts | Endocrinology and Metabolism(대한내분비학회지) |
| 2021 | Lobeglitazone: A Novel Thiazolidinedione for the Management of Type 2 Diabetes Mellitus | Diabetes and Metabolism Journal |
| 2021 | Nonalcoholic fatty liver disease, diastolic dysfunction, and impaired myocardial glucose uptake in patients with type 2 diabetes | DIABETES OBESITY & METABOLISM |
| 2021 | The Association of Calcium and Vitamin D Use With Implant Survival of Total Knee Arthroplasty: A Nationwide Population-Based Cohort Study | JOURNAL OF ARTHROPLASTY |
| 2021 | Glycaemic control with add-on thiazolidinedione or a sodium-glucose co-transporter-2 inhibitor in patients with type 2 diabetes after the failure of an oral triple antidiabetic regimen: A 24-week, randomized controlled trial | DIABETES OBESITY & METABOLISM |
| 2020 | Dipeptidyl peptidase-4 inhibitor protects against non-alcoholic steatohepatitis in mice by targeting TRAIL receptor-mediated lipoapoptosis via modulating hepatic dipeptidyl peptidase-4 expression | SCIENTIFIC REPORTS |
| 2020 | Effect of Switching from Linagliptin to Teneligliptin Dipeptidyl Peptidase-4 Inhibitors in Older Patients with Type 2 Diabetes Mellitus | DIABETES METABOLIC SYNDROME AND OBESITY-TARGETS AND THERAPY |
| 2020 | SGLT2 inhibition modulates NLRP3 inflammasome activity via ketones and insulin in diabetes with cardiovascular disease | NATURE COMMUNICATIONS |
| 2020 | Significance of Soluble CD93 in Type 2 Diabetes as a Biomarker for Diabetic Nephropathy: Integrated Results from Human and Rodent Studies | JOURNAL OF CLINICAL MEDICINE |
| 2019 | The Effectiveness of Intermittent Fasting to Reduce Body Mass Index and Glucose Metabolism: A Systematic Review and Meta-Analysis | JOURNAL OF CLINICAL MEDICINE |
http://orcid.org/0000-0002-9333-7512
